ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

Trial locations(40 sites)

United States

Clinical Trial Site, La Jolla, California

Clinical Trial Site, Los Angeles, California

Clinical Trial Site, Jacksonville, Florida

Clinical Trial Site, Iowa City, Iowa

Clinical Trial Site, Kansas City, Kansas

Clinical Trial Site, Baltimore, Maryland

Clinical Trial Site, Boston, Massachusetts

Clinical Trial Site, New York, New York

Clinical Trial Site, Durham, North Carolina

Clinical Trial Site, Columbus, Ohio

Clinical Trial Site, Philadelphia, Pennsylvania

Clinical Trial Site, Austin, Texas

Clinical Trial Site, Houston, Texas

Brazil

Clinical Trial Site, Salvador

Clinical Trial Site, São Paulo

Bulgaria

Clinical Trial Site, Sofia

Denmark

Clinical Trial Site, Aarhus

Clinical Trial Site, Copenhagen

France

Clinical Trial Site, Bordeaux

Clinical Trial Site, Bron

Clinical Trial Site, Créteil

Clinical Trial Site, Le Kremlin-Bicêtre

Clinical Trial Site, Marseille

Germany

Clinical Trial Site, Berlin

Clinical Trial Site, Giessen

Clinical Trial Site, Hanover

Israel

Clinical Trial Site, Jerusalem

Clinical Trial Site, Ramat Gan

Italy

Clinical Trial Site, Milan

Clinical Trial Site, Naples

Clinical Trial Site, Palermo

Clinical Trial Site, Roma

Netherlands

Clinical Trial Site, Groningen

Portugal

Clinical Trial Site, Lisbon

Clinical Trial Site, Porto

Spain

Clinical Trial Site, Barcelona

Clinical Trial Site, Madrid

Clinical Trial Site, Palma

Taiwan

Clinical Trial Site, New Taipei City

Clinical Trial Site, Taipei